Last $136.10 USD
Change Today +5.19 / 3.96%
Volume 825.9K
As of 8:10 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kathryn E. Falberg

AgeTotal Calculated CompensationThis person is connected to 29 board members in 2 different organizations across 12 different industries.

See Board Relationships
52$4,098,007
As of Fiscal Year 2012

Background*

Ms. Kathryn E. Falberg, also known as Kate, has been a Consultant to Jazz Pharmaceuticals Public Limited Company since March 9, 2014. Ms. Falberg served as the Chief Financial Officer of Jazz Pharmaceuticals Public Limited Company from 2009 to March 9, 2014 and its Executive Vice President since March 2012 until February 2014. Ms. Falberg serves as the Chief Financial Officer and Senior Vice President of Azur Pharma Limited. She is responsible for Jazz's accounting, ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: --

Board Members Memberships*

Director
2002-N/A
Former Director, Member of Audit Committee and Member of Compensation Committee
2004-N/A
Former Independent Director
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2009-2012
Former Director, Chairman of Audit & Risk Committee and Member of Corporate Governance & Nominating Committee
2013-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

BA
University of California-Los Angeles
MBA
University of California-Los Angeles

Other Affiliations*

Annual Compensation*

Salary$446,769
Total Annual Compensation$446,769

Stock Options*

Restricted Stock Awards$1,639,047
All Other Compensation$2,622
Exercised Options141,830
Exercised Options Value$4,813,775
Exercisable Options40,815
Exercisable Options Value$1,873,409
Unexercisable Options87,355
Unexercisable Options Value$1,230,507
Total Value of Options$7,917,690
Total Number of Options270,000

Total Compensation*

Total Annual Cash Compensation$839,391
Total Short Term Compensation$446,769
Other Long Term Compensation$1,641,669
Total Calculated Compensation$4,098,007
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $136.10 USD +5.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$821.1K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Larry Hsu Ph.D.Chief Executive Officer, President and Director
Impax Laboratories Inc.
$742.2K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$834.1K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.